Abstract:Background: The number of diabetic patients has recently been increasing worldwide. Diabetes is a multifactorial disorder based on environmental factors and genetic background. In many cases, diabetes is asymptomatic for a long period and the patient is not aware of the disease. Therefore, the potential biomarker(s), leading to the early detection and/or prevention of diabetes mellitus, are strongly required. However, the diagnosis of the prediabetic state in humans is a very difficult issue, because the lifestyle is variable its each person. Although the development of a diagnosis method in humans is the goal of our research, the extraction and structural identification of biomarker candidates in several biological specimens (i.e., plasma, hair, liver and kidney) of ddY strain mice, which undergo naturally occurring diabetes along with aging, were carried out based upon a metabolite profiling study.Methods: The low-molecular-mass compounds including metabolites in the biological specimens of diabetic mice (ddY-H) and normal mice (ddY-L) were globally separated by ultra-performance liquid chromatography (UPLC) using different reversed-phase columns (i.e.. T3-C18 and HS-F5) and detected by electrospray ionization time-of-flight mass spectrometry (ESI-TOF-MS). The biomarker candidates related to diabetes mellitus were extracted from a multivariate statistical analysis, such as an orthogonal partial least-squares-discriminant analysis (OPLS-DA). followed by a database search, such as ChemSpider. KEGG and HMDB.Results: Many metabolites and unknown compounds in each biological specimen were detected as the biomarker candidates related to diabetic mellitus. Among them, the elucidation of the chemical structures of several possible metabolites. including more than two biological specimens, was carried out along with the comparison of the tandem MS/MS analyses using authentic compounds. One metabolite was clearly identified as N-acetyl-L-leucine based upon the MS/MS spectra and the retention time on the chromatograms.Conclusions: N-acetyl-L-leucine is an endogenous compound included in all biological specimens (plasma, hair, liver and kidney). Therefore, this metabolite appears to be a potential biomarker candidate related to diabetes. Although the structures of other biomarker candidates have still not yet determined, the present approach based upon a metabolite profiling study using UPLC-ESI-TOF-MS could be helpful for understanding the abnormal state of various diseases. (C) 2010 Elsevier B.V. All rights reserved.

Metabonomics Research of Diabetes Mellitus and Diabetic Nephropathy Based on Uplc-Oatof-Ms System

Systemic Perturbations Of Key Metabolites In Diabetic Rats During The Evolution Of Diabetes Studied By Urine Metabonomics

Analysis of Urinary Proteomic Patterns for Diabetic Nephropathy by ProteinChip.

Discovery and Comparison of Serum Biomarkers for Diabetes Mellitus and Metabolic Syndrome Based on UPLC-Q-TOF/MS

Advanced Mass Spectrometry-Based Biomarker Identification for Metabolomics of Diabetes Mellitus and Its Complications

Ultraviolet and Tandem Mass Spectrometry for Simultaneous Quantification of 21 Pivotal Metabolites in Plasma from Patients with Diabetic Nephropathy

Biomarker Discovery in Biological Specimens (plasma, Hair, Liver and Kidney) of Diabetic Mice Based Upon Metabolite Profiling Using Ultra-Performance Liquid Chromatography with Electrospray Ionization Time-Of-Flight Mass Spectrometry

A Comparative Study of Elution Gradients in UPLC-TOF-MS-Based Metabonomics Research

Serum and Urinary Metabolomic Analysis in Patients with Diabetic Nephropathy

Serum and urine metabolomics reveal potential biomarkers of T2DM patients with nephropathy

Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy.

Phospholipidomic Identification of Potential Plasma Biomarkers Associated with Type 2 Diabetes Mellitus and Diabetic Nephropathy.

Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis.

Practical Analytical Approach for the Identification of Biomarker Candidates in Prediabetic State Based Upon Metabonomic Study by Ultraperformance Liquid Chromatography Coupled to Electrospray Ionization Time-of-flight Mass Spectrometry.

Identification of Potential Serum Metabolic Biomarkers of Diabetic Kidney Disease: A Widely Targeted Metabolomics Study

Preliminary Observational Study of Metabonomics in Patients with Early and Late-Onset Type 2 Diabetes Mellitus Based on UPLC-Q-TOF/MS

Serum Metabolic Profiling of Type 2 Diabetes Mellitus in Chinese Adults Using an Untargeted GC/TOFMS

Analysis Of Serum Metabolomics Among Biopsy-Proven Diabetic Nephropathy, Type 2 Diabetes Mellitus And Healthy Controls

Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease

Plasma Targeted Metabolomics Analysis for Amino Acids and Acylcarnitines in Patients with Prediabetes, Type 2 Diabetes Mellitus, and Diabetic Vascular Complications

Nuclear Magnetic Resonance-Based Metabonomics and Its Application for Diabetes